CHANGE Act of 2021
- Last Action
- 5/20/2021
Actions
- 2021-05-20Referred to the Subcommittee on Health.
- 2021-05-19Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-05-19Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-05-19Introduced in House
- 2021-05-19Introduced in House
CRS Summary
As of 2021-05-19 (00)
Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2021 or the CHANGE Act of 2021
This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.
Additionally, the Centers for Medicare & Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.
The Government Accountability Office also must conduct a study of policies that may accelerate progress in Alzheimer's disease research and enhance the quality of care for individuals diagnosed with Alzheimer's disease.
Cosponsors (20)
- Darin LaHood (R-IL)
- Doris Matsui (D-CA)
- FRED UPTON (R-MI)
- Mikie Sherrill (D-NJ)
- Nanette Barragan (D-CA)
- Bill Posey (R-FL)
- Haley Stevens (D-MI)
- Brian Fitzpatrick (R-PA)
- Alan Lowenthal (D-CA)
- ELEANOR NORTON (D-DC)
- Peter Welch (D-VT)
- Adam Kinzinger (R-IL)
- MAXINE WATERS (D-CA)
- Marie Newman (D-IL)
- PETER DEFAZIO (D-OR)
- Tom Cole (R-OK)
- Thomas Suozzi (D-NY)
- Val Demings (D-FL)
- Glenn Grothman (R-WI)
- MIKE DOYLE (D-PA)
Subjects
- Aging
- Congressional oversight
- Government studies and investigations
- Health care costs and insurance
- Health care quality
- Health information and medical records
- Health promotion and preventive care
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Neurological disorders
- Public-private cooperation
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.